Menu
ಕನ್ನಡ ePaper
State National Ayodhya Special Sandhyavani Videos Stories Photos Exclusive IPL 2021 World Cup 2023 Sports International Business Election-2023 Entertainment Top 10 News Automobile Health and Lifestyle Cartoon Category Picks From Web Top 20 News ePaper Contact Us Premium Content Lok Sabha 2024 Paris Olympics
Advertisement

Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo

09:14 AM Mar 22, 2022 | PTI |

New Delhi: Sun Pharmaceutical Industries on Monday said it has entered into a share purchase agreement with Japan’s Daiichi Sankyo Company to acquire the latter’s 11.28 percent stake in Zenotech Laboratories.

Advertisement

Sun Pharma said it will pay Rs 5.32 crore for the stake.

The primary objective of the transaction from the acquirer’s perspective is to consolidate its holding in the target company, the Mumbai-based drug firm said in a regulatory filing.

After the acquisition, Sun Pharma’s stake in Zenotech will increase from 57.56 percent to 68.84 percent, it added.

Related Articles

Top 20 News

Protests against land acquisition for 'pharma village' in Telangana turns violent
State

Geethartha Chinthane 102: Self-development vs. self-contraction
State

Geethartha Chinthane 101: Understanding of universality eases grief
State

Geethartha Chinthane-100: Grief after death, not during dying!
State

Geethartha Chinthane-99: Arjuna seemed like a wise man
State

Geethartha Chinthane 98: Delusion is natural, clinging to it is mistake
State

Geethartha Chinthane 97: Replacing delusion with sense of duty
State

Geethartha Chintane 96: Web of delusion vs. awakened self
State

Geethartha Chinthane 95: Gudakesha's prayer to Hrishikesha
State

Geethartha Chinthane-94: Listening to distress as a remedy

The acquisition is expected to complete in 30 days.

Advertisement
Subscribe
Advertisement

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Next